LIGAND PHARMACEUTICALS INC (LGND) has 315 open-market insider trades by 35 insiders since 2006. Over the last six months insiders net sold $7.0M. The most active filer is John L. Higgins, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Daniel S. Loeb | — | — | 2 | $64.1M | 2007-03-26 |
| John L. Higgins | Dir | — | 37 | $61.3M | 2022-12-28 |
| David M. Knott Jr. | Dir | — | 33 | $56.6M | 2015-08-17 |
| Jason Aryeh | Dir | — | 35 | $49.8M | 2026-06-11 |
| BVF Inc/il | 10% | — | 8 | $45.7M | 2013-11-27 |
| Matthew W. Foehr | PresCOO | — | 23 | $40.8M | 2022-11-01 |
| BVF Investments LLC | — | — | 5 | $35.7M | 2014-02-20 |
| Biotechnology VALUE FUND II L.P. | — | — | 8 | $29.6M | 2014-03-25 |
| Charles S. Berkman | VPSecretary | — | 19 | $27.3M | 2022-11-01 |
| Matthew E. Korenberg | PresCOO | — | 7 | $25.1M | 2024-09-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Andrew Reardon | CLO & Secretary | Sell | $1.5M | 2026-10-02 |
| Martine Zimmermann | Director | Sell | $342K | 2026-09-10 |
| Andrew Reardon | CLO & Secretary | Sell | $1.4M | 2026-09-03 |
| Octavio Espinoza | CFO | Sell | $9.2M | 2026-08-12 |
| Jason Haas | Director | Sell | $2.1M | 2026-08-12 |
| Andrew Reardon | CLO & Secretary | Sell | $1.4M |
Companies that share insiders with LGND, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-08-03 |
| Andrew Reardon | CLO & Secretary | Sell | $1.6M | 2026-07-01 |
| Stephen L. Sabba | Director | Sell | $545K | 2026-06-16 |
| Jason Haas | Director | Sell | $1.7M | 2026-06-12 |
| John L. Lamattina | Director | Sell | $1.2M | 2026-06-10 |
| Jason Aryeh | Director | Sell | $1.3M | 2026-06-10 |
| Andrew Reardon | CLO & Secretary | Sell | $1.1M | 2026-06-01 |
| Andrew Reardon | CLO & Secretary | Sell | $1.2M | 2026-05-01 |
| John W. Kozarich | Director | Sell | $563K | 2026-05-01 |
| Andrew Reardon | CLO & Secretary | Sell | $1.0M | 2026-04-01 |